Wall Street optimistic for July 4 weekend, sees opportunities in Freeport-McMoRan, Honeywell, Caterpillar, and Amgen.

Following its acquisition by Supernus Pharmaceuticals, Sage Therapeutics has let go of all of its remaining workforce, which ...

GlobalData has predicted that bemarituzumab could make US sales of $500 million in the US alone in the next 10 years. Gastric cancer is particularly prevalent in Asia-Pacific countries, a key ...